The Argenta Global Leadership Team assembled in Lawrence, KS, USA on May 13–15, 2019 to meet and discuss the future of animal health with customers and thought leaders from industry, and to start shaping the strategy for Argenta in its next phase of growth. Not only is the US $30 billion animal health industry growing at 5-6% per annum, it is also changing rapidly as larger companies are spun off from their human health parents and seek new sources and pathways to innovation. According to Stonehaven Consulting AG, there have been over 600 new entrants into the sector in recent years. Collectively they are changing the way innovation and new products come to market, presenting both risks and opportunities for all industry players. It was great to gain insights from Aaron Schacht, Fabian Kausche, Craig Tooman, Ernst Heinen and Stonehaven Consulting AG, and valuable to have our Argenta Global Leadership Team together face-to-face to develop a robust strategy that will guide us in our journey.

Pictured above in the group picture are from left to right:

Front row kneeling: Graeme Ying (General Manager – New Zealand); Mark Gibson (Board Director); Adrian Grosu (Stonehaven Consulting); Ben Russell (CEO)

Back row standing: Dr Stephen Bienhoff (Chief Scientific Officer of AlcheraBio); Bryan Beaird (Head of AlcheraBio); Phil Huse (VP Customer Relationships – CMO); Vishal Agarwal (Head of Pharmaceutical Sciences – New Zealand); Rana Ali (Global Head of Innovation); Tasi Pocock (Head of People and Performance); Jacqui Farini (General Manager – Argenta Dundee, UK); Dave Baardson (GM – AML Riverside, USA); Dr Johnny Jacobsen (Global Head of Customer Relationships): Bruce Wallace (Global Head of Quality); Darrell Morgan (VP Customer Relationships – CRO); Stephen Sibson (Global Head of Manufacturing); Matthias Hofer (Stonehaven Consulting); Chris O’Donnell (Chief Financial Officer)

Missing from the group picture: Ben Isaacs (Head of Pharmaceutical Sciences – USA)